Press Coverage

•      The patient had severe narrowing of the heart valve
•      He only had 10 percent survival chances when he came to the hospital
•      Aortic valve Stenosis one of the most prevalent heart diseases globally
•      TAVR is a minimally invasive procedure that repairs the aortic heart valve without removing the old, damaged valve

Gurugram, November 27, 2019: Paras Hospitals, Gurugram, known for performing multitude of advanced cardiac procedure, has become one of the first hospitals in Delhi & NCR to successfully performed the first Transcatheter Aortic Heart Valve Replacement (TAVR) Myval on an 84-year-old patient, Mr. VK, who had severe narrowing of the heart valve and was advised high risk open heart surgery with the risk of death.

TAVR is the new treatment modality for patients who are at risk or unwilling to undergo open heart valve replacement surgery. TAVR is a minimally invasive procedure that repairs the aortic heart valve without removing the old, damaged valve. Instead, it places a replacement valve through a catheter or tube inserted through the femoral artery (the large artery in the groin). The TAVR procedure is also beneficial for treating patients with previously failed bioprosthetic valve, hence preventing an additional surgical intervention.

Associate director and United head cardiology, Dr Amit Bhushan Sharma, who has pioneered the structural heart disease revolution at Paras with many firsts to his credit namely the first TAVR procedure then the world’s smallest pacemaker stroke protection device to name a few said the patient had gone into the repeated heart failure and had a 10 percent survival chances when he came to the Paras Hospitals.

“The heart team headed by Dr Amit Bhushan Sharma also included Dr Fayaz, Rather cardiologist Echo, Cardiography and Radiology team and Intensivists Dr Pratyush and Dr Nitin Jain successfully performed the first TAVR  Myvalv at the Paras Hospitals, Gurgaon recently on a patient, who had severe narrowing of the heart valve. This highly symptomatic patient who was hardly able to walk even a few steps greatly benefited from this surgery and is miraculously now able to perform all normal activities all within a span of 36 hours,” said Dr Amit Bhushan Sharma.

According to the multiple reports, India has 1 million cases of aortic stenosis mainly due to age related degradation of the aortic valve—an important cause not only in India but in other parts of the world as well. Although less invasive procedure to replace the valve is the much sought after treatment today, the number of such procedures is comparatively less in India due to cost and access issues.

“There are multiple benefits of the procedure being minimally invasive. It aids faster recovery, minimizes the chances of infection is less painful involves shorter hospital stay for the patient, less scarring or surgery marks, and decreases the chances of injuries to nearby structures said Dr sharma .If we see the estimates, Aortic valve stenosis is one of the most prevalent heart diseases globally and the number of cases at any conservative estimate would cross 3 to 3.5 per cent of the elderly population,” added Dr Sharma.

Myval is most advanced therapy for transcatheter aortic valve replacement It is the country’s first indigenous Make in India initiative Transcatheter Aortic Heart Valve Replacement (TAVR) device, which has got coveted CE and Central Drugs Standard Control Organization (CDSCO) approval. The CE certification would enable Myval-THV to reach over 60 countries in Europe and outside of India which accept CE mark document for their own regulatory approvals.